Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
<h4>Background</h4>Acute decompensation (AD) of liver cirrhosis (LC) and subsequent acute-on-chronic liver failure (ACLF) are fatal and impair quality of life. Insufficient knowledge of the highly heterogeneous natural history of LC, including decompensation, re-compensation, and possibl...
Saved in:
| Main Authors: | Hitomi Hoshi, Po-Sung Chu, Aya Yoshida, Nobuhito Taniki, Rei Morikawa, Karin Yamataka, Fumie Noguchi, Ryosuke Kasuga, Takaya Tabuchi, Hirotoshi Ebinuma, Hidetsugu Saito, Takanori Kanai, Nobuhiro Nakamoto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0250062&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of T cells on immune-related liver diseases: an overview
by: Yuzo Koda, et al.
Published: (2025-07-01) -
The Use of Extracorporeal Liver Support Systems In Acute Decompensated Liver Failure
by: R. A. Ibadov, et al.
Published: (2021-08-01) -
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
by: Takumi Hirata, et al.
Published: (2013-01-01) -
Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
by: Takumi Hirata, et al.
Published: (2014-01-01) -
Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia
by: Filipa Ventura, et al.
Published: (2010-01-01)